TY - JOUR
T1 - Incorporation of type I collagen molecules that contain a mutant α2(I) chain (Gly580 → Asp) into bone matrix in a lethal case of osteogenesis imperfecta
AU - Niyibizi, Christopher
AU - Bonadio, Jeffrey
AU - Byers, Peter H.
AU - Eyre, David R.
N1 - Copyright:
Copyright 2004 Elsevier B.V., All rights reserved.
PY - 1992/11/15
Y1 - 1992/11/15
N2 - To understand more directly the tissue defect in osteogenesis imperfecta (OI), bone matrix was analyzed from an infant with lethal OI (type II) of defined mutation (collagen α2(I)Gly580 → Asp). Pepsin-solubilized al(I) and α2(1) chains and derived CNBr-peptides migrated more slowly on sodium dodecyl sulfate-polyacrylamide gel electrophoresis compared with normal human controls. The peptide α2(I)CB3,5, predicted to contain the mutation site, ran as a retarded doublet band and was purified by high performance liquid chromatography and digested with V8 protease. Two peptides with amino-terminal sequences beginning at residue 576 of the α2(I) chain were isolated. One had the normal sequence. The other differed in that aspartic acid replaced glycine at residue 580 as predicted from cDNA analysis, and in having an unhydroxylated proline at residue 579. From yields on microsequencing and the relative intensities of the two forms of α2(I)CB3,5 on SDS-polyacrylamide gel electrophoresis, the ratio of mutant to normal α2(I) chains in the infant's bone matrix was 0.7/1. Although the effects of an efficient incorporation of mutant chains on the properties of the bone matrix are unknown, it may be that in this OI case the tissue abnormalities result more from the presence of mutant protein than from an underexpression of matrix.
AB - To understand more directly the tissue defect in osteogenesis imperfecta (OI), bone matrix was analyzed from an infant with lethal OI (type II) of defined mutation (collagen α2(I)Gly580 → Asp). Pepsin-solubilized al(I) and α2(1) chains and derived CNBr-peptides migrated more slowly on sodium dodecyl sulfate-polyacrylamide gel electrophoresis compared with normal human controls. The peptide α2(I)CB3,5, predicted to contain the mutation site, ran as a retarded doublet band and was purified by high performance liquid chromatography and digested with V8 protease. Two peptides with amino-terminal sequences beginning at residue 576 of the α2(I) chain were isolated. One had the normal sequence. The other differed in that aspartic acid replaced glycine at residue 580 as predicted from cDNA analysis, and in having an unhydroxylated proline at residue 579. From yields on microsequencing and the relative intensities of the two forms of α2(I)CB3,5 on SDS-polyacrylamide gel electrophoresis, the ratio of mutant to normal α2(I) chains in the infant's bone matrix was 0.7/1. Although the effects of an efficient incorporation of mutant chains on the properties of the bone matrix are unknown, it may be that in this OI case the tissue abnormalities result more from the presence of mutant protein than from an underexpression of matrix.
UR - http://www.scopus.com/inward/record.url?scp=0026488378&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026488378&partnerID=8YFLogxK
M3 - Article
C2 - 1385413
AN - SCOPUS:0026488378
SN - 0021-9258
VL - 267
SP - 23108
EP - 23112
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 32
ER -